Citigroup Inc Merck & Co., Inc. Transaction History

Citigroup Inc

$150 Billion
Q1 2024

A detailed history of Citigroup Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Citigroup Inc holds 4,710,061 shares of MRK stock, worth $583 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

4,710,061

Previous 4,096,963 14.96%

Holding current value

$583 Million

Previous $447 Million 39.15%

% of portfolio

0.41%

Previous 0.32%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$113.24 - $131.95 $69.4 Million - $80.9 Million	613,098 Added 14.96%	4,710,061 $621 Million
Q4 2023 Feb 09, 2024	SELL	$100.18 - $109.02 $10.5 Million - $11.4 Million	-104,673 Reduced 2.49%	4,096,963 $447 Million
Q3 2023 Nov 09, 2023	BUY	$102.95 - $114.33 $16.3 Million - $18.1 Million	157,988 Added 3.91%	4,201,636 $433 Million
Q2 2023 Aug 10, 2023	SELL	$108.61 - $118.38 $2.9 Million - $3.17 Million	-26,736 Reduced 0.66%	4,043,648 $467 Million
Q1 2023 May 11, 2023	BUY	$102.94 - $114.86 $31 Million - $34.6 Million	301,346 Added 8.0%	4,070,384 $433 Million

Q4 2022 Feb 09, 2023	BUY	$87.44 - $112.11 $5.71 Million - $7.33 Million	65,347 Added 1.76%	3,769,038 $418 Million
Q3 2022 Nov 10, 2022	SELL	$84.53 - $94.96 $17.6 Million - $19.7 Million	-207,836 Reduced 5.31%	3,703,691 $319 Million
Q2 2022 Aug 10, 2022	SELL	$83.49 - $94.64 $4.61 Million - $5.22 Million	-55,163 Reduced 1.39%	3,911,527 $357 Million
Q1 2022 May 12, 2022	SELL	$73.51 - $82.4 $59.9 Million - $67.2 Million	-815,476 Reduced 17.05%	3,966,690 $325 Million
Q4 2021 Feb 10, 2022	BUY	$72.28 - $90.54 $21.4 Million - $26.8 Million	295,895 Added 6.6%	4,782,166 $367 Million
Q3 2021 Nov 10, 2021	BUY	$71.68 - $78.83 $322 Million - $354 Million	4,486,271 New	4,486,271 $337 Million

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account